Plain-English translation of NCT05930210 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a Phase 3 clinical trial testing a medication called to treat diabetic foot ulcers. Half of the 230 participants will apply this new gel to their wound twice daily for 16 weeks, while the other half will apply a placebo gel that looks and feels the same but has no active ingredient. The study will measure how well the medication works compared to placebo and track any side effects.
Diabetic foot ulcers are serious wounds that often heal slowly or not at all, sometimes leading to infection or amputation. Researchers are testing this new treatment to see if it can help these wounds close faster and more reliably than current standard care alone.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic for a screening appointment 2–3 weeks before the study starts. Then, for 16 weeks, you would apply either the new gel or placebo gel to your foot ulcer twice daily at home. You'll have regular clinic visits to have your wound measured and checked. After the 16-week treatment period ends, you'll continue coming to visits for another 12 weeks of safety monitoring. The entire study commitment is approximately 7 months.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States